Results 121 to 130 of about 556,257 (242)
Global and Episode-Specific Prediction of Recurrent Events Using Longitudinal Health Informatics Data. [PDF]
Sun Y, Chiou SH, Huang CY.
europepmc +1 more source
Objective The objective of the study was to determine risk factors for relapse of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) after reinduction of remission with rituximab and discontinuation of maintenance therapy. Methods This is a post hoc analysis of the RITAZAREM clinical trial.
Ellen Romich +62 more
wiley +1 more source
Principles and implementation strategies for equitable and representative academic partnerships in global health informatics research. [PDF]
Campbell E +7 more
europepmc +1 more source
Digital health and health informatics
Hasman, Arie +2 more
openaire +3 more sources
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes (PROs) in youth with axial juvenile spondyloarthritis (axJSpA) initiating tumor necrosis factor inhibitor (TNFi).
Timothy G. Brandon +8 more
wiley +1 more source
Engagements with Generative AI and Personal Health Informatics: Opportunities for Planning, Tracking, Reflecting, and Acting around Personal Health Data. [PDF]
Chopra S +3 more
europepmc +1 more source
FAIR Health Informatics: A Health Informatics Framework for Verifiable and Explainable Data Analysis. [PDF]
Siddiqi MH, Idris M, Alruwaili M.
europepmc +1 more source
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020).
Tate M. Johnson +13 more
wiley +1 more source
Advancing a learning health system through biomedical and health informatics. [PDF]
Bakken S.
europepmc +1 more source
Objective Osteoporosis causes fractures which further increase the disease burden of rheumatoid arthritis (RA), however, osteoporosis treatment rates remain low. While several studies have reported that biologic or targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) can prevent or improve osteoporosis in RA, our large‐scale, real ...
Takafumi Aritomi +30 more
wiley +1 more source

